Analysis of Bias Criteria Checklist for Wound Care Registries & EHRs
Summary: The 2019 USWR white paper argues chronic wounds (affecting ~15% Medicare patients, up to $96.8B annual costs) are symptoms of systemic issues with high comorbidities—making RCT evidence unrepresentative. It promotes registry-based real-world data for evaluating advanced therapies (biologicals/synthetics) in real patients, introducing the ABCs checklist to minimize biases in observational studies. Supports unbiased assessment of products like synthetic matrices in heterogeneous populations.
Key Highlights:
- Burden: 8.2M Medicare patients; surgical dehiscence/common “no-name” wounds prevalent.
- Thesis: Registries > RCTs for real-world efficacy; USWR as QCDR since 2014.
- ABCs Checklist: Addresses selection/information/channeling/analytical bias via transparent reporting.
- Implications: Enables comparative effectiveness for advanced wound care in comorbid cases.
Keywords: real-world evidence, chronic wounds, US Wound Registry, bias checklist, advanced therapies